SYNTHESIS OF PYRAZOLO[3,4-d]PYRIMIDINONES

Authors

  • Feruza Ruzieva Author
  • Davron Turgunov Author
  • Mutazaeva Zarifa Author
  • Khurshed Bozorov Author

Keywords:

2-Methyl-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2- a]pyrimidin-4(2H)-one, methyl 3-amino-1-methyl-1H-pyrazole-4-carboxylate, piperidin-2-one, phosphoryl chloride.

Abstract

.2-Methyl-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2- a]pyrimidin-4(2H)-one was synthesized as a result of the cyclization reaction of methyl 3-amino-1-methyl-1H-pyrazole-4-carboxylate with piperidin-2-one.

References

1. Ahmed M. Abdelhamed, Rasha A. Hassan, Novel pyrazolo[3,4-

d]pyrimidine derivatives: design, synthesis, anticancer evaluation,

VEGFR-2 inhibition, and antiangiogenic activity, RSC Medicinal

Chemistry. https://doi.org/10.1039/D3MD00476G

2. Monika Chauhan, Raj Kumar, Medicinal attributes of pyrazolo[3,4-

d]pyrimidines: a review, Bioorganic & Medicinal Chemistry, 2013,

https://doi.org/10.1016/j.bmc.2013.07.0274

3. Zukela Ruzi, Khurshed Bozorov, Lifei Nie, Jiangyu Zhao, Haji Akber

Aisa, Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action, Biomedicine

& Pharmacotherapy, 2022. https://doi.org/10.1016/j.biopha.2022.1139485

4. Zukela Ruzi, et al., Discovery of novel (E)-1-methyl-9-(3-

methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-

a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular

docking, and anticancer properties, Bioorganic Chemistry, 2023, 135:

106506

Published

2026-04-01

Similar Articles

11-19 of 19

You may also start an advanced similarity search for this article.